Impact of COVID-19 on Pediatric Asthma: Practice Adjustments and Disease Burden.
Adherence
Asthma
COVID-19
Children
Control
SARS-CoV2
Virus
Journal
The journal of allergy and clinical immunology. In practice
ISSN: 2213-2201
Titre abrégé: J Allergy Clin Immunol Pract
Pays: United States
ID NLM: 101597220
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
08
05
2020
revised:
25
05
2020
accepted:
01
06
2020
pubmed:
21
6
2020
medline:
18
9
2020
entrez:
21
6
2020
Statut:
ppublish
Résumé
It is unclear whether asthma may affect susceptibility or severity of coronavirus disease 2019 (COVID-19) in children and how pediatric asthma services worldwide have responded to the pandemic. To describe the impact of the COVID-19 pandemic on pediatric asthma services and on disease burden in their patients. An online survey was sent to members of the Pediatric Asthma in Real Life think tank and the World Allergy Organization Pediatric Asthma Committee. It included questions on service provision, disease burden, and the clinical course of confirmed cases of COVID-19 infection among children with asthma. Ninety-one respondents, caring for an estimated population of more than 133,000 children with asthma, completed the survey. COVID-19 significantly impacted pediatric asthma services: 39% ceased physical appointments, 47% stopped accepting new patients, and 75% limited patients' visits. Consultations were almost halved to a median of 20 (interquartile range, 10-25) patients per week. Virtual clinics and helplines were launched in most centers. Better than expected disease control was reported in 20% (10%-40%) of patients, whereas control was negatively affected in only 10% (7.5%-12.5%). Adherence also appeared to increase. Only 15 confirmed cases of COVID-19 were reported among the population; the estimated incidence is not apparently different from the reports of general pediatric cohorts. Children with asthma do not appear to be disproportionately affected by COVID-19. Outcomes may even have improved, possibly through increased adherence and/or reduced exposures. Clinical services have rapidly responded to the pandemic by limiting and replacing physical appointments with virtual encounters.
Sections du résumé
BACKGROUND
It is unclear whether asthma may affect susceptibility or severity of coronavirus disease 2019 (COVID-19) in children and how pediatric asthma services worldwide have responded to the pandemic.
OBJECTIVE
To describe the impact of the COVID-19 pandemic on pediatric asthma services and on disease burden in their patients.
METHODS
An online survey was sent to members of the Pediatric Asthma in Real Life think tank and the World Allergy Organization Pediatric Asthma Committee. It included questions on service provision, disease burden, and the clinical course of confirmed cases of COVID-19 infection among children with asthma.
RESULTS
Ninety-one respondents, caring for an estimated population of more than 133,000 children with asthma, completed the survey. COVID-19 significantly impacted pediatric asthma services: 39% ceased physical appointments, 47% stopped accepting new patients, and 75% limited patients' visits. Consultations were almost halved to a median of 20 (interquartile range, 10-25) patients per week. Virtual clinics and helplines were launched in most centers. Better than expected disease control was reported in 20% (10%-40%) of patients, whereas control was negatively affected in only 10% (7.5%-12.5%). Adherence also appeared to increase. Only 15 confirmed cases of COVID-19 were reported among the population; the estimated incidence is not apparently different from the reports of general pediatric cohorts.
CONCLUSIONS
Children with asthma do not appear to be disproportionately affected by COVID-19. Outcomes may even have improved, possibly through increased adherence and/or reduced exposures. Clinical services have rapidly responded to the pandemic by limiting and replacing physical appointments with virtual encounters.
Identifiants
pubmed: 32561497
pii: S2213-2198(20)30599-7
doi: 10.1016/j.jaip.2020.06.001
pmc: PMC7297686
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2592-2599.e3Subventions
Organisme : Medical Research Council
ID : MR/K002449/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K002449/2
Pays : United Kingdom
Investigateurs
Rola Abou Taam
(RA)
Hugo Azuara
(H)
Jacques Brouard
(J)
Pierrick Cros
(P)
Cindy De Lira
(C)
Jean-Christophe Dubus
(JC)
Teija Dunder
(T)
Kamilla Efendieva
(K)
Carole Egron
(C)
Andrzej Emeryk
(A)
Yunuen R Huerta Villalobos
(YR)
Nidia Karen
(N)
Pascal Le Roux
(P)
Julia Levina
(J)
Monica Medley
(M)
Major Najaraju
(M)
Daniela Rivero Yeverino
(DR)
Marja Ruotsalainen
(M)
Stanley Szefler
(S)
Cyril Schweitzer
(C)
Berenice Velasco Benhumea
(BV)
Rosalaura Villarreal
(R)
Laurence Weiss
(L)
Anna Zawadzka-Krajewska
(A)
Informations de copyright
Copyright © 2020 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Références
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
JAMA Pediatr. 2020 Apr 8;:
pubmed: 32267485
Respir Investig. 2020 May;58(3):155-168
pubmed: 32094077
Infection. 2020 Jun;48(3):445-452
pubmed: 32301099
Ecancermedicalscience. 2020 Mar 30;14:1023
pubmed: 32256706
Clin Exp Allergy. 2018 May;48(5):536-543
pubmed: 29473978
Nat Med. 2020 Apr;26(4):465
pubmed: 32273605
J Allergy Clin Immunol Pract. 2020 May;8(5):1477-1488.e5
pubmed: 32224232
J Allergy Clin Immunol. 2020 Jul;146(1):110-118
pubmed: 32294485
MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):422-426
pubmed: 32271728
N Engl J Med. 2020 Apr 2;382(14):1370-1371
pubmed: 32163697
Pediatr Allergy Immunol. 2019 Feb;30(1):7-16
pubmed: 30312503
Thorax. 2018 Nov;73(11):1049-1061
pubmed: 29748253
Pediatrics. 2020 Jun;145(6):
pubmed: 32179660
JAMA. 2020 Apr 28;323(16):1559-1560
pubmed: 32250408
N Engl J Med. 2020 Apr 23;382(17):1663-1665
pubmed: 32187458
Acta Paediatr. 2020 Jul;109(7):1497-1498
pubmed: 32279351
N Engl J Med. 2020 Apr 30;382(18):1679-1681
pubmed: 32160451
J Allergy Clin Immunol. 2020 Jun;145(6):1529-1534
pubmed: 32081759
Allergy. 2020 Sep;75(9):2170-2184
pubmed: 31916265
World Allergy Organ J. 2020 May 14;13(5):100125
pubmed: 32411315
J Allergy Clin Immunol. 2020 Jul;146(1):203-206.e3
pubmed: 32333915
Pediatr Pulmonol. 2019 Apr;54(4):372-377
pubmed: 30672140
J Korean Med Sci. 2020 Mar 16;35(10):e112
pubmed: 32174069
J Allergy Clin Immunol Pract. 2020 Jun;8(6):1953-1960.e9
pubmed: 32146166